Inici > Esdeveniments & Notícies > Barcelona Global Update > The antiviral drug Remdesivir reduces the time to recovery in COVID-19 patients, according to a first trial test conducted by the Hospital Clinic and ISGlobal
The antiviral drug Remdesivir reduces the time to recovery in COVID-19 patients, according to a first trial test conducted by the Hospital Clinic and ISGlobal
